Michael ‘Wippa’ Wipfli: Nova radio host admits to using pricey weight loss drug Mounjaro
A Nova radio host has admitted live on-air to taking a weight loss drug popular with celebrities that costs an arm and a leg ...
Novo Nordisk Earnings Must Show GLP-1 Market Still Set for Big Growth
Novo’s Wegovy and Ozempic are among the most closely watched new medications in recent history, but face serious competition from Eli Lilly’s Zepbound and Mounjaro.
Novo Nordisk's Wegovy Drug Sales Miss Expectations
Novo Nordisk's blockbuster Wegovy weight-loss drug just missed sales expectations in the fourth quarter despite more than doubling on the year. The Danish pharmaceutical giant said sales of Wegovy ...
Radio star Michael 'Wippa' Wipfli admits to taking celebrity weight loss drug - and reveals the shocking price he pays for it each month
Michael 'Wippa' Wipfli made a bombshell admission live on-air on Wednesday that he was taking an expensive celebrity weight ...
Euro Weekly News18h
Weight-loss jabs are now classed as “high risk”, requiring stricter regulations
Access to weight-loss jabs will now be more tightly regulated in the UK following concerns of pharmacies not prescribing them ...
Ozempic crackdown: What you need to know about the new rules
Around half a million Britons are now thought to be using the medication, which can help them lose up to 20 per cent of their ...